On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...